[HTML][HTML] A novel Huntington's disease assessment platform to support future drug discovery and development

J Wu, L Möhle, T Brüning, I Eiriz, M Rafehi… - International Journal of …, 2022 - mdpi.com
Huntington's disease (HD) is a lethal neurodegenerative disorder without efficient
therapeutic options. The inefficient translation from preclinical and clinical research into …

A Novel Huntington's Disease Assessment Platform to Support Future Drug Discovery and Development

J Wu, L Möhle, T Brüning, I Eiriz… - International …, 2022 - search.proquest.com
Huntington's disease (HD) is a lethal neurodegenerative disorder without efficient
therapeutic options. The inefficient translation from preclinical and clinical research into …

A Novel Huntington's Disease Assessment Platform to Support Future Drug Discovery and Development

J Wu, L Möhle, T Brüning, I Eiriz, M Rafehi… - 2022 - publications.goettingen-research …
Huntington's disease (HD) is a lethal neurodegenerative disorder without efficient
therapeutic options. The inefficient translation from preclinical and clinical research into …

[HTML][HTML] A Novel Huntington's Disease Assessment Platform to Support Future Drug Discovery and Development

J Wu, L Möhle, T Brüning, I Eiriz, M Rafehi… - … Journal of Molecular …, 2022 - ncbi.nlm.nih.gov
Huntington's disease (HD) is a lethal neurodegenerative disorder without efficient
therapeutic options. The inefficient translation from preclinical and clinical research into …

A Novel Huntington's Disease Assessment Platform to Support Future Drug Discovery and Development

J Wu, L Möhle, T Brüning, I Eiriz Delgado… - International Journal of …, 2022 - duo.uio.no
Huntington's disease (HD) is a lethal neurodegenerative disorder without efficient
therapeutic options. The inefficient translation from preclinical and clinical research into …

A Novel Huntington's Disease Assessment Platform to Support Future Drug Discovery and Development.

J Wu, L Möhle, T Brüning, I Eiriz… - International …, 2022 - search.ebscohost.com
Huntington's disease (HD) is a lethal neurodegenerative disorder without efficient
therapeutic options. The inefficient translation from preclinical and clinical research into …

[PDF][PDF] A novel Huntington's disease assessment platform to support future drug discovery and development

J Wu, L Möhle, T Brüning, I Eiriz, M Rafehi… - 2022 - opus.bibliothek.uni-augsburg.de
Huntington's disease (HD) is a lethal neurodegenerative disorder without efficient
therapeutic options. The inefficient translation from preclinical and clinical research into …

A Novel Huntington's Disease Assessment Platform to Support Future Drug Discovery and Development.

J Wu, L Möhle, T Brüning, I Eiriz, M Rafehi… - … Journal of Molecular …, 2022 - europepmc.org
Huntington's disease (HD) is a lethal neurodegenerative disorder without efficient
therapeutic options. The inefficient translation from preclinical and clinical research into …

[PDF][PDF] A Novel Huntington's Disease Assessment Platform to Support Future Drug Discovery and Development

J Wu, L Möhle, T Brüning, I Eiriz, M Rafehi, K Stefan… - Int. J. Mol. Sci, 2022 - text2fa.ir
Huntington's disease (HD) is a lethal neurodegenerative disorder without efficient
therapeutic options. The inefficient translation from preclinical and clinical research into …

A Novel Huntington's Disease Assessment Platform to Support Future Drug Discovery and Development

J Wu, L Möhle, T Brüning, I Eiriz… - International …, 2022 - pubmed.ncbi.nlm.nih.gov
Huntington's disease (HD) is a lethal neurodegenerative disorder without efficient
therapeutic options. The inefficient translation from preclinical and clinical research into …